Effect of a Toothpaste and Serum Compared to Standard Fluoride Toothpaste on Gingival Health Over a Six Month Period.

June 6, 2018 updated by: Unilever R&D

A Study to Measure the Effect of a Toothpaste Containing Zinc Citrate Trihydrate Used in Combination With a Serum Containing Zinc Sulphate Heptahydrate and a Standard Fluoride Toothpaste on Gingival Health Over a Six Month Period.

This study is a double-blind, randomised, parallel group efficacy study. Up to 240 healthy female and male participants aged over 18 years will participate. There will be two groups of up to 120 participants. Participants will be randomised to the test groups according the allocation table prepared by the Statistician.

Participants will be enrolled on to the study according to the inclusion/exclusion criteria. After enrollment participants will have their teeth that have been allocated for assessment cleaned using a professional prophylaxis polish by the study dentist. The participants will then be provided with a standard cosmetic silica Fluoride toothpaste and a toothbrush to use at home, twice a day for up to four weeks. After this time they will return to the test site and have the baseline dental assessments. Participants will then be randomly allocated to one of the two test products which they will use at home, twice a day for the duration of the study. Dental assessments will be conducted after 13 and 26 weeks of product use at the study site.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

222

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bristol, United Kingdom, BS1 2LY
        • Bristol Dental Hospital and School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Be aged 18 years and over, of either gender and in good health.
  • Be willing and physically able to carry out all study procedures.
  • Be willing and competent (verbally and cognitively) to give written informed consent and complete a medical history form.
  • Have at least 20 natural teeth including 5 teeth (excluding 3rd molars) in each quadrant
  • Have at least 6 natural teeth assessable teeth in the Upper 4 to 4 region.
  • Have a mean Modified Gingival Index (MGI) score of 2 at screening in the Upper 4 to 4 region.
  • Not have had a scale and prophylaxis in the month prior to enrolment or have one scheduled prior to the end of the study.
  • Be willing to use the test products for 6 months

Exclusion Criteria:

  • Current participation in any other cosmetic trials, any dental clinical trials or clinical trials.
  • Pregnant or nursing women.
  • Medical condition and/or regular use of any medication which might affect the outcome of the study, as determined by the study dentist, principally a course of anti-inflammatory, antimicrobial or statin drugs
  • Obvious signs of untreated caries or significant periodontal disease, which in the opinion of the Study Dentist, will affect either the scientific validity of the study or if the participants was to participate in the study would affect their wellbeing.
  • Any participant who, in the judgement of the investigator, should not participate in the study.
  • Full or partial dentures wearers.
  • Current orthodontic treatment.
  • Have oral piercings.
  • Smokers or those who have a recent smoking history.
  • Taking dietary supplements (e.g. multivitamins; antioxidants; fish oils).
  • Any subject with a single MGI score of 4 in the any area of the mouth at any time point will be excluded.
  • A subject will be excluded from the study if they have a MGI mouth mean of >2.75 at screening
  • Any subject with a single MGI score of 3 at Baseline
  • Use of non study oral care products, e.g. dental floss, chewing gum, mouth rinses during the pre treatment and test phases of the study.
  • The subject is an employee of Unilever or a member of the study team.
  • Taking a course of antimicrobial or anti-inflammatory drugs within 4 weeks of screening
  • Those taking anti-histamine or anti-inflammatory medication in the 24 hours prior to the dental assessments
  • Diabetics

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Treatment
Toothpaste containing 1.11% Fluoride as Sodium Monofluorophosphate and Zinc Citrate Trihydrate Serum containing 0.17% Fluoride as Sodium Monofluorophosphate and Zinc Sulphate Heptahydrate
F13/T38
Other: Comparator
Silica toothpaste 1350ppm F as Sodium Fluoride
M26

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in gingival condition as assessed using the Modified Lobene Gingival Index
Time Frame: 13 weeks
13 weeks
Change in gingival condition as assessed using the Saxton and van der Ouderaa bleeding index
Time Frame: 13 weeks
13 weeks
Change in gingival condition as assessed using the Modified Quigley and Hein plaque index
Time Frame: 13 weeks
13 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in gingival condition as assessed using the Modified Lobene Gingival Index
Time Frame: 26 weeks
26 weeks
Change in gingival condition as assessed using the Saxton and van der Ouderaa bleeding index
Time Frame: 26 weeks
26 weeks
Change in gingival condition as assessed using the Modified Quigley and Hein plaque index
Time Frame: 26 weeks
26 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Nicola X West, BDS, Bristol Dental Hospital and School

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 3, 2015

Primary Completion (Actual)

December 14, 2015

Study Completion (Actual)

March 14, 2016

Study Registration Dates

First Submitted

December 3, 2015

First Submitted That Met QC Criteria

February 3, 2016

First Posted (Estimate)

February 8, 2016

Study Record Updates

Last Update Posted (Actual)

June 8, 2018

Last Update Submitted That Met QC Criteria

June 6, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ORL-GUM-2101

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Treatment

Subscribe